Table 1.
Patents’ baseline characteristics.
| IAD (n = 49) | EAD (n = 311) | p-Value | |
|---|---|---|---|
| EASI score (mean ± SD) | 18.2 ± 11.97 | 24.04 ± 10.34 | <0.01 |
| H&N EASI score (mean ± SD) | 2.6 ± 2.09 | 3.33 ± 2.1 | <0.05 |
| DLQI (mean ± SD) | 14.13 ± 7.56 | 14.88 ± 7.07 | 0.496 |
| POEM (mean ± SD) | 19.19 ± 6.56 | 20.8 ± 6.31 | 0.094 |
| NRSpp (mean ± SD) | 8.63 ± 1.44 | 8.56 ± 1.75 | 0.759 |
| NRSsd (mean ± SD) | 6.85 ± 2.83 | 7.07 ± 3.15 | 0.258 |
| LDH (mean ± SD) | 289 ± 125.42 | 327.12 ± 147.16 | 0.095 |
| IgE kU/L (mean ± SD) | 70.64 ± 60.05 | 3949.74 ± 5208.77 | <0.001 |
| Eosinophils × 109/L (mean ± SD) | 0.31 ± 0.39 | 0.2 ± 9.07 | <0.01 |
IAD: Intrinsic atopic dermatitis; EAD: extrinsic atopic dermatitis; SD: standard deviation; EASI: eczema area severity index; H&N = head and neck; DLQI: dermatology life quality index; POEM: patient-oriented eczema measure; NRSpp: numerical rating scale peak of pruritus; NRSsd: numerical rating scale sleep disturbance.